| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| OCTAGAM 50 mg/ml | IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA | SOL. PERF. | J06BA02 | W65624001 | OCTAPHARMA (IP) SPRL - BELGIA | ||||||
| OCTAGAM 50 mg/ml | IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA | SOL. PERF. | J06BA02 | W65624002 | OCTAPHARMA (IP) SPRL - BELGIA | ||||||
| OCTAGAM 50 mg/ml | IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA | SOL. PERF. | J06BA02 | W65624003 | OCTAPHARMA (IP) SPRL - BELGIA | ||||||
| OCTAGAM 50 mg/ml | IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA | SOL. PERF. | J06BA02 | W65624004 | OCTAPHARMA (IP) SPRL - BELGIA | ||||||
| OCTAGAM 50 mg/ml | IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA | SOL. PERF. | J06BA02 | W65624005 | OCTAPHARMA (IP) SPRL - BELGIA | ||||||
| OCTAGAM 50 mg/ml | IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA | SOL. PERF. | J06BA02 | W65624006 | OCTAPHARMA (IP) SPRL - BELGIA | ||||||
| OCTAGAM 50 mg/ml | IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA | SOL. PERF. | J06BA02 | W65624007 | OCTAPHARMA (IP) SPRL - BELGIA | ||||||
| OCTAGAM 10% | IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA | SOL. PERF. | J06BA02 | W65903001 | OCTAPHARMA (IP) SPRL - BELGIA | ||||||
| OCTAGAM 10% | IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA | SOL. PERF. | J06BA02 | W65903002 | OCTAPHARMA (IP) SPRL - BELGIA | ||||||
| OCTAGAM 10% | IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA | SOL. PERF. | J06BA02 | W65903003 | OCTAPHARMA (IP) SPRL - BELGIA | ||||||
| OCTAGAM 10% | IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA | SOL. PERF. | J06BA02 | W65903004 | OCTAPHARMA (IP) SPRL - BELGIA | ||||||
| OCTAGAM 10% | IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA | SOL. PERF. | J06BA02 | W65903005 | OCTAPHARMA (IP) SPRL - BELGIA | ||||||
| OCTAGAM 10% | IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA | SOL. PERF. | J06BA02 | W65903006 | OCTAPHARMA (IP) SPRL - BELGIA | ||||||
| OCTAGAM 10% | IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA | SOL. PERF. | J06BA02 | W65903007 | OCTAPHARMA (IP) SPRL - BELGIA | ||||||
| OCREVUS 920 mg | OCRELIZUMABUM | SOL. INJ. | L04AG08 | W70385001 | ROCHE REGISTRATION GMBH - GERMANIA | X | |||||
| OCREVUS 300 mg | OCRELIZUMABUM | CONC. PT. SOL. PERF. | L04AG08 | W64485001 | ROCHE REGISTRATION GMBH - GERMANIA | X | |||||
| OBIZUR 500 U | SUSOCTOCOG ALFA | PULB.+SOLV. PT. SOL. INJ. | B02BD14 | W66930001 | BAXALTA INNOVATIONS GMBH - AUSTRIA | X | |||||
| OBIZUR 500 U | SUSOCTOCOG ALFA | PULB.+SOLV. PT. SOL. INJ. | B02BD14 | W66930002 | BAXALTA INNOVATIONS GMBH - AUSTRIA | X | |||||
| OBIZUR 500 U | SUSOCTOCOG ALFA | PULB.+SOLV. PT. SOL. INJ. | B02BD14 | W66930003 | BAXALTA INNOVATIONS GMBH - AUSTRIA | X | |||||
| NYVEPRIA 6 mg | PEGFILGRASTIMUM | SOL. INJ. | L03AA13 | W69561001 | PFIZER EUROPE MA EEIG - BELGIA | X |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman